Investment
Features
FeesSafety
Academy
More
Pluang+

Victrex earnings hit lows but Stifel sees buying chance with new CEO's turnaround plan.

Analyst Insights
23 Jun 2026
Proactive Investors
View Source
Bullish
pluang ai news

Victrex PLC, a leader in high-performance polymers, has seen earnings fall to their lowest since 2009 due to competition and operational issues. Stifel initiated coverage with a 'buy' rating, citing new CEO Jakob Sigurd Routh's efforts to cut costs and improve efficiency, targeting over £10 million in savings by 2027. Investors await a September capital markets day for more on the turnaround strategy. The shares trade at a discount to their five-year average, offering an attractive entry point with potential for profit recovery.

More News

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...

Market News
Bearish
1 hour ago
DNRS revamps digital platform with 9thCO, adopting composable architecture for seamless user experience.

DNRS revamps digital platform with 9thCO, adopting composable architecture for seamless user experience.

Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...

Others
Bullish
1 hour ago
Willis Towers Watson stock could rise 25% on new digital sales and advanced analytics innovations.

Willis Towers Watson stock could rise 25% on new digital sales and advanced analytics innovations.

Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...

Analyst Insights
Bullish
3 hours ago
AngioDynamics jumps on strong Q4 sales and raised price target to $19 by H.C. Wainwright

AngioDynamics jumps on strong Q4 sales and raised price target to $19 by H.C. Wainwright

AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...

Company Fundamentals
Bullish
3 hours ago
PNC beats Q2 earnings estimates with record revenue, but shares fall on expense and deposit concerns.

PNC beats Q2 earnings estimates with record revenue, but shares fall on expense and deposit concerns.

PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App